Luo Zixin, Lv Jialian, Zou Kang
The First Clinical Medical College, Gannan Medical University, Ganzhou City, Jiangxi, China.
Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou City, Jiangxi, China.
Front Med (Lausanne). 2025 Mar 4;12:1553970. doi: 10.3389/fmed.2025.1553970. eCollection 2025.
Critical illness medicine faces challenges such as high data complexity, large individual differences, and rapid changes in conditions. Artificial Intelligence (AI) technology, especially machine learning and deep learning, offers new possibilities for addressing these issues. By analyzing large amounts of patient data, AI can help identify diseases earlier, predict disease progression, and support clinical decision-making.
In this study, scientific literature databases such as Web of Science were searched, and bibliometric methods along with visualization tools R-bibliometrix, VOSviewer 1.6.19, and CiteSpace 6.2.R4 were used to perform a visual analysis of the retrieved data.
This study analyzed 900 articles from 6,653 authors in 82 countries between 2005 and 2024. The United States is a major contributor in this field, with Harvard University having the highest betweenness centrality. Noseworthy PA is a core author in this field, and and lead other journals in terms of the number of publications. Artificial Intelligence has tremendous potential in the identification and management of heart failure and sepsis.
The application of AI in critical illness holds great potential, particularly in enhancing diagnostic accuracy, personalized treatment, and clinical decision support. However, to achieve widespread application of AI technology in clinical practice, challenges such as data privacy, model interpretability, and ethical issues need to be addressed. Future research should focus on the transparency, interpretability, and clinical validation of AI models to ensure their effectiveness and safety in critical illness.
危重病医学面临着数据复杂性高、个体差异大以及病情变化迅速等挑战。人工智能(AI)技术,尤其是机器学习和深度学习,为解决这些问题提供了新的可能性。通过分析大量患者数据,人工智能可以帮助更早地识别疾病、预测疾病进展并支持临床决策。
本研究检索了科学引文索引(Web of Science)等科学文献数据库,并使用文献计量学方法以及可视化工具R-bibliometrix、VOSviewer 1.6.19和CiteSpace 6.2.R4对检索到的数据进行可视化分析。
本研究分析了2005年至2024年间来自82个国家6653位作者的900篇文章。美国是该领域的主要贡献者,哈佛大学的中介中心性最高。Noseworthy PA是该领域的核心作者, 在发表数量方面领先于其他期刊。人工智能在心力衰竭和脓毒症的识别与管理方面具有巨大潜力。
人工智能在危重病中的应用具有巨大潜力,特别是在提高诊断准确性、个性化治疗和临床决策支持方面。然而,要使人工智能技术在临床实践中得到广泛应用,需要解决数据隐私、模型可解释性和伦理问题等挑战。未来的研究应侧重于人工智能模型的透明度、可解释性和临床验证,以确保其在危重病中的有效性和安全性。